- Home
- ALEC vs PSNYW Comparison
ALEC vs PSNYW Comparison
Compare ALEC & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | PSNYW |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | Sweden |
| Employees | N/A | 2547 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.2M | 290.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALEC | PSNYW |
|---|---|---|
| Price | $2.18 | $3.06 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 437.9K | 6.3K |
| Earning Date | 05-04-2026 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $21,045,000.00 | ★ $2,034,261,000.00 |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $29.87 | $79.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $0.14 |
| 52 Week High | $3.40 | $7.50 |
Technical Indicators
Market Signals| Indicator | ALEC | PSNYW |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 44.26 |
| Support Level | $1.89 | $2.88 |
| Resistance Level | $2.57 | $3.99 |
| Average True Range (ATR) | 0.16 | 0.32 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 24.46 | 19.27 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.